Actively Recruiting

Age: 18Years +
All Genders
ID07606066

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Led by AstraZeneca · Updated on 2026-05-26

3000

Participants Needed

40

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying patients with Type 2 Diabetes Mellitus (T2DM) to identify and describe their characteristics for possible involvement in current or future clinical trials focused on T2DM. The study aims to understand medication use patterns among these patients across different regions and better characterize their health status. Participants include adults with T2DM who are managed either through lifestyle changes alone or with stable doses of glucose-lowering medicines. The study involves a one-time visit during which participants will undergo assessments including blood collection (about 2 mL) and evaluation of their medical history, demographics, medication use, and blood sugar levels measured by HbA1c. During the single visit, researchers will collect information about medical and surgical history, current medications, and demographic data. They will measure HbA1c levels to assess blood sugar control and may refer participants to other ongoing or future T2DM studies. The study focuses on observation and data collection without active treatment, lasting only one day for each participant.

CONDITIONS

Brief Title

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be 18 years of age or older at the time of signing the informed consent form.
  • Diagnosed with Type 2 Diabetes Mellitus confirmed by testing or medical records according to WHO or local standards.
  • Diabetes is managed either by lifestyle changes alone or with a stable dose of glucose-lowering medication(s) for at least 45 days before consenting.
  • Interested and willing to participate in ongoing or future Type 2 Diabetes clinical studies and able to follow study procedures.
  • Provide signed and dated informed consent before any study procedures or tests.
Not Eligible

You will not qualify if you...

  • Current or planned use of GLP-1 receptor agonists that are prohibited in ongoing or future investigational studies.
  • Diagnosis of Type 1 diabetes mellitus.
  • Known pregnancy or intention to become pregnant at the time of the visit.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants undergo assessments including blood sampling and medical history review.

1 visit (in-person)

Trial Site Locations

Total: 40 locations

1

Research Site

Lincoln, California, United States, 95648

Actively Recruiting

2

Research Site

Ocoee, Florida, United States, 34761

Not Yet Recruiting

3

Research Site

Decatur, Georgia, United States, 30030

Not Yet Recruiting

4

Research Site

Potomac, Maryland, United States, 20854

Not Yet Recruiting

5

Research Site

Gaffney, South Carolina, United States, 29340

Not Yet Recruiting

6

Research Site

Renton, Washington, United States, 98057

Not Yet Recruiting

7

Research Site

Fortaleza, Ceará, Brazil, 60430-350

Not Yet Recruiting

8

Research Site

Curitiba, Paraná, Brazil, 80030-480

Not Yet Recruiting

9

Research Site

Natal, Rio Grande do Norte, Brazil, 59020-035

Not Yet Recruiting

10

Research Site

Porto Alegre, Rio Grande do Sul, Brazil, 90630-165

Not Yet Recruiting

11

Research Site

Campinas, São Paulo, Brazil, 13060-904

Not Yet Recruiting

12

Research Site

São José dos Campos, São Paulo, Brazil, 12243-280

Not Yet Recruiting

13

Research Site

São Paulo, São Paulo, Brazil, 01228-200

Not Yet Recruiting

14

Research Site

São Paulo, São Paulo, Brazil, 04012-180

Not Yet Recruiting

15

Research Site

Barretos, Brazil, 14784-400

Not Yet Recruiting

16

Research Site

Brasília, Brazil, 71625-009

Not Yet Recruiting

17

Research Site

Rio de Janeiro, Brazil, 22270-060

Not Yet Recruiting

18

Research Site

Tianjin, China, 300457

Not Yet Recruiting

19

Research Site

Seremban, Negeri Sembilan, Malaysia, 70300

Not Yet Recruiting

20

Research Site

Seri Manjung, Perak, Malaysia, 32040

Not Yet Recruiting

21

Research Site

Batu Caves, Selangor, Malaysia, 68100

Not Yet Recruiting

22

Research Site

Kuala Lumpur, Wilayah Persekutuan Kuala Lump, Malaysia, 59100

Not Yet Recruiting

23

Research Site

Putrajaya, Malaysia, 62250

Not Yet Recruiting

24

Research Site

Lublin, Lublin Voivodeship, Poland, 20-718

Not Yet Recruiting

25

Research Site

Krakow, Malopolska, Poland, 31-261

Not Yet Recruiting

26

Research Site

Radom, Masovian Voivodeship, Poland, 26-600

Not Yet Recruiting

27

Research Site

Bialystok, Podlaskie Voivodeship, Poland, 15-879

Not Yet Recruiting

28

Research Site

Częstochowa, Silesian Voivodeship, Poland, 42-217

Not Yet Recruiting

29

Research Site

Poznan, Poland, 60-354

Not Yet Recruiting

30

Research Site

Warsaw, Poland, 00-124

Not Yet Recruiting

31

Research Site

Lodz, Łódź Voivodeship, Poland, 90-338

Not Yet Recruiting

32

Research Site

Kielce, Świętokrzyskie Voivodeship, Poland, 25-355

Not Yet Recruiting

33

Research Site

Yüreğir, Adana, Turkey (Türkiye), 1240

Not Yet Recruiting

34

Research Site

Ankara, Turkey, Turkey (Türkiye), 6100

Not Yet Recruiting

35

Research Site

Adana, Turkey (Türkiye), 1060

Not Yet Recruiting

36

Research Site

Ankara, Turkey (Türkiye), 6530

Not Yet Recruiting

37

Research Site

Gaziantep, Turkey (Türkiye), 27470

Not Yet Recruiting

38

Research Site

Istanbul, Turkey (Türkiye), 34300

Not Yet Recruiting

39

Research Site

Istanbul, Turkey (Türkiye), 34384

Not Yet Recruiting

40

Research Site

Kayseri, Turkey (Türkiye), 38039

Not Yet Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

The PILI 'Aina Project to Improve Cardiometabolic Health in...

Type 2 Diabetes

Actively Recruiting

2 locations

A Clinical Study to Evaluate the Pharmacokinetic and Pharmac...

Type 2 Diabetes

Actively Recruiting

1 location

A Feasibility Study of Optimal Non-Pharmacological Lifestyle...

Type 2 Diabetes

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here